197 related articles for article (PubMed ID: 20962581)
1. Detailed specificity analysis of antibodies binding to modified histone tails with peptide arrays.
Bock I; Dhayalan A; Kudithipudi S; Brandt O; Rathert P; Jeltsch A
Epigenetics; 2011 Feb; 6(2):256-63. PubMed ID: 20962581
[TBL] [Abstract][Full Text] [Related]
2. Specificity Analysis of Histone Modification-Specific Antibodies or Reading Domains on Histone Peptide Arrays.
Kungulovski G; Kycia I; Mauser R; Jeltsch A
Methods Mol Biol; 2015; 1348():275-84. PubMed ID: 26424280
[TBL] [Abstract][Full Text] [Related]
3. From spots to beads-PTM-peptide bead arrays for the characterization of anti-histone antibodies.
Heubach Y; Planatscher H; Sommersdorf C; Maisch D; Maier J; Joos TO; Templin MF; Poetz O
Proteomics; 2013 Mar; 13(6):1010-5. PubMed ID: 23401470
[TBL] [Abstract][Full Text] [Related]
4. Application of modified histone peptide arrays in chromatin research.
Mauser R; Jeltsch A
Arch Biochem Biophys; 2019 Jan; 661():31-38. PubMed ID: 30391375
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Histone Antibody Specificity with Peptide Microarrays.
Cornett EM; Dickson BM; Rothbart SB
J Vis Exp; 2017 Aug; (126):. PubMed ID: 28809825
[TBL] [Abstract][Full Text] [Related]
6. Application of Celluspots peptide arrays for the analysis of the binding specificity of epigenetic reading domains to modified histone tails.
Bock I; Kudithipudi S; Tamas R; Kungulovski G; Dhayalan A; Jeltsch A
BMC Biochem; 2011 Aug; 12():48. PubMed ID: 21884582
[TBL] [Abstract][Full Text] [Related]
7. Affinity reagents for studying histone modifications & guidelines for their quality control.
Kungulovski G; Mauser R; Jeltsch A
Epigenomics; 2015 Oct; 7(7):1185-96. PubMed ID: 26541466
[TBL] [Abstract][Full Text] [Related]
8. Examining the Roles of H3K4 Methylation States with Systematically Characterized Antibodies.
Shah RN; Grzybowski AT; Cornett EM; Johnstone AL; Dickson BM; Boone BA; Cheek MA; Cowles MW; Maryanski D; Meiners MJ; Tiedemann RL; Vaughan RM; Arora N; Sun ZW; Rothbart SB; Keogh MC; Ruthenburg AJ
Mol Cell; 2018 Oct; 72(1):162-177.e7. PubMed ID: 30244833
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive structural analysis of mutant nucleosomes containing lysine to glutamine (KQ) substitutions in the H3 and H4 histone-fold domains.
Iwasaki W; Tachiwana H; Kawaguchi K; Shibata T; Kagawa W; Kurumizaka H
Biochemistry; 2011 Sep; 50(36):7822-32. PubMed ID: 21812398
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of chromatin immunoprecipitation grade antibodies directed against histone modifications reveals patterns of co-occurring marks on histone protein molecules.
Peach SE; Rudomin EL; Udeshi ND; Carr SA; Jaffe JD
Mol Cell Proteomics; 2012 May; 11(5):128-37. PubMed ID: 22442256
[TBL] [Abstract][Full Text] [Related]
11. Influence of combinatorial histone modifications on antibody and effector protein recognition.
Fuchs SM; Krajewski K; Baker RW; Miller VL; Strahl BD
Curr Biol; 2011 Jan; 21(1):53-8. PubMed ID: 21167713
[TBL] [Abstract][Full Text] [Related]
12. Mapping of linear histone regions exposed at the surface of the nucleosome in solution.
Stemmer C; Briand JP; Muller S
J Mol Biol; 1997 Oct; 273(1):52-60. PubMed ID: 9367745
[TBL] [Abstract][Full Text] [Related]
13. Role of histone N-terminal tails and their acetylation in nucleosome dynamics.
Morales V; Richard-Foy H
Mol Cell Biol; 2000 Oct; 20(19):7230-7. PubMed ID: 10982840
[TBL] [Abstract][Full Text] [Related]
14. Recombinant antibodies to histone post-translational modifications.
Hattori T; Taft JM; Swist KM; Luo H; Witt H; Slattery M; Koide A; Ruthenburg AJ; Krajewski K; Strahl BD; White KP; Farnham PJ; Zhao Y; Koide S
Nat Methods; 2013 Oct; 10(10):992-5. PubMed ID: 23955773
[TBL] [Abstract][Full Text] [Related]
15. Chasing Tails: Cathepsin-L Improves Structural Analysis of Histones by HX-MS.
Papanastasiou M; Mullahoo J; DeRuff KC; Bajrami B; Karageorgos I; Johnston SE; Peckner R; Myers SA; Carr SA; Jaffe JD
Mol Cell Proteomics; 2019 Oct; 18(10):2089-2098. PubMed ID: 31409669
[TBL] [Abstract][Full Text] [Related]
16. Poly-acetylated chromatin signatures are preferred epitopes for site-specific histone H4 acetyl antibodies.
Rothbart SB; Lin S; Britton LM; Krajewski K; Keogh MC; Garcia BA; Strahl BD
Sci Rep; 2012; 2():489. PubMed ID: 22761995
[TBL] [Abstract][Full Text] [Related]
17. Application of histone modification-specific interaction domains as an alternative to antibodies.
Kungulovski G; Kycia I; Tamas R; Jurkowska RZ; Kudithipudi S; Henry C; Reinhardt R; Labhart P; Jeltsch A
Genome Res; 2014 Nov; 24(11):1842-53. PubMed ID: 25301795
[TBL] [Abstract][Full Text] [Related]
18. A General Method to Edit Histone H3 Modifications on Chromatin Via Sortase-Mediated Metathesis.
Yang Q; Gao Y; Liu X; Xiao Y; Wu M
Angew Chem Int Ed Engl; 2022 Dec; 61(52):e202209945. PubMed ID: 36305862
[TBL] [Abstract][Full Text] [Related]
19. Broad ranges of affinity and specificity of anti-histone antibodies revealed by a quantitative peptide immunoprecipitation assay.
Nishikori S; Hattori T; Fuchs SM; Yasui N; Wojcik J; Koide A; Strahl BD; Koide S
J Mol Biol; 2012 Dec; 424(5):391-9. PubMed ID: 23041298
[TBL] [Abstract][Full Text] [Related]
20. Multiple Sclerosis: Enzymatic Cross Site-Specific Hydrolysis of H1 Histone by IgGs against H1, H2A, H2B, H3, H4 Histones, and Myelin Basic Protein.
Nevinsky GA; Baranova SV; Buneva VN; Dmitrenok PS
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
